You have read all your free articles, to continue reading subscribe to read the rest of this content.
The company will extend funding for its award-winning Young Health Programme for a further five years with a pledge of $35 million to help to educate young people on the steps they can take to reduce the risk of non-communicable diseases. These diseases, which include cancer, diabetes, heart diseAlready a…
This event will offer a week of biotech, pharma and finance, including several very interesting on demand sessions. The digital event, October 25-28, will include one-to-one meetings, company presentations, company showcases and interesting keynotes and panels. Global decision makers from biotechAlready a subscriber Login You have read all your free…
The partners in Pandemic Antiviral Discovery (PAD) initiative has announced grants totalling more than USD 26 million for 14 research projects aimed at facilitating early-stage development of drugs to treat henipavirus infection and disease in humans. These grants mark the majority of the first iAlready a subscriber Login You have…
In June this year, Carlos de Sousa commenced his role as Chief Executive Officer of Norwegian Ultimovacs, a pharmaceutical company developing novel immunotherapies against cancer. Congratulations on your new position! What made you say yes, or apply for the job? “Ultimovacs presented a uniquAlready a subscriber Login You have read…
